HeartSciences Inc.
HSCS · NASDAQ
4/30/2025 | 4/30/2024 | 4/30/2023 | 4/30/2022 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -76.6% | 261.2% | -64.2% | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 56.8% | 67.3% | 45.7% | 45.1% |
| R&D Expenses | $4 | $3 | $2 | $3 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $4 | $3 | $4 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $8 | $6 | $6 | $5 |
| Operating Income | -$8 | -$6 | -$6 | -$5 |
| % Margin | -192,013.1% | -33,902% | -118,698.3% | -32,765.6% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$9 | -$7 | -$6 | -$5 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$9 | -$7 | -$491 | -$5 |
| % Margin | -201,499.5% | -35,511.9% | -9,531,151.3% | -31,851.8% |
| EPS | -9.34 | -18.74 | -6,173.88 | -137.94 |
| % Growth | 50.2% | 99.7% | -4,375.8% | – |
| EPS Diluted | -9.34 | -18.74 | -6,173.88 | -137.94 |
| Weighted Avg Shares Out | 1 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 1 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$8 | -$6 | -$6 | -$4 |
| % Margin | -187,053.3% | -33,096.7% | -118,139.8% | -30,822.2% |